Suchergebnisse - "Samitas, Konstantinos"

PubPharm (73)

1

Switching from omalizumab to mepolizumab in severe asthmatics : A post hoc analysis of the RELight study

enthalten in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology | 2024

von Kallieri, M. | Papaioannou, A. | Zervas, E. | +31

2

Evaluation of real-world mepolizumab use in severe asthma across Europe : the SHARP experience with privacy-preserving federated analysis

enthalten in: ERJ open research | 2023

von Kroes, J. | Alfonso-Cristancho, R. | Bansal, A. | +41

3

Successful and safe treatment of severe steroid depended eosinophilic asthma with mepolizumab in a woman during pregnancy

enthalten in: Respiratory medicine case reports | 2023

von Vittorakis, S. | Giannakopoulou, G. | Samitas, K. | +1

4

Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era : The European EXOTIC Registry

enthalten in: JTO clinical and research reports | 2023

von Mountzios, G. | Planchard, D. | Metro, G. | +36

5

SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics

enthalten in: The journal of allergy and clinical immunology. In practice | 2022

von Papaioannou, A. | Fouka, E. | Tzanakis, N. | +36

6

RELIght : A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: Evaluating the multiple components of response

enthalten in: Allergy | 2022

von Kallieri, M. | Zervas, E. | Fouka, E. | +31

7

TFEB signaling attenuates NLRP3-driven inflammatory responses in severe asthma

enthalten in: Allergy | 2022

von Theofani, E. | Semitekolou, M. | Samitas, K. | +11

8

Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab : results from a European multicentre study

enthalten in: Therapeutic advances in medical oncology | 2022

von Dimitrakopoulos, F. | Mountzios, G. | Christopoulos, P. | +22

9

Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab : results from a European multicentre study

enthalten in: Therapeutic advances in medical oncology | September 8, 2022

von Dimitrakopoulos, F. | Mountzios, G. | Christopoulos, P. | +22

10

TFEB signaling attenuates NLRP3‐driven inflammatory responses in severe asthma

enthalten in: Allergy | 2022

von Theofani, E. | Semitekolou, M. | Samitas, K. | +11

1
2
3
4
5
6
7
8
Nächster »
[8]